Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
728 - Hi Patrick - I've read the 2019 Client Survey report on the PAAB website. Is there a plan to disseminate this more broadly, and what actions is the PAAB taking with regards to any of the specific survey results? Thank you.
-
The 2019 Client Insight research has been posted to the PAAB website and is available for access by the broader public. The PAAB is constantly working through the results to try and update processes and procedures. We will be looking to industry and the community to help shape new endeavours. Please follow us and stay tuned to the PAAB website, LinkedIn and Twitter (@ThePAAB) for opportunities to join new committees to help shape change.
